These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 3519022

  • 21. Aminoglycoside nephrotoxicity: keys to prevention.
    Levin ML.
    J Crit Illn; 1994 Oct; 9(10):911-2, 915. PubMed ID: 10150695
    [Abstract] [Full Text] [Related]

  • 22. Antibiotic nephrotoxicity. A review of pathogenesis and prevention.
    Silverblatt FJ.
    Urol Clin North Am; 1975 Oct; 2(3):557-67. PubMed ID: 1103415
    [No Abstract] [Full Text] [Related]

  • 23. Additive nephrotoxicity of cephalosporins and aminoglycosides in the rabbit.
    Bendirdjian JP, Prime DJ, Browning MC, Hsu CY, Tune BM.
    J Pharmacol Exp Ther; 1981 Sep; 218(3):681-5. PubMed ID: 7264951
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Pathogenetic mechanisms of nephrotoxicity: insights into cyclosporine nephrotoxicity.
    Humes HD, Jackson NM, O'Connor RP, Hunt DA, White MD.
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):51-62. PubMed ID: 3895671
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Morphology of cyclosporine nephrotoxicity in the rat.
    Mihatsch MJ, Ryffel B, Hermle M, Brunner FP, Thiel G.
    Clin Nephrol; 1986 Aug; 25 Suppl 1():S2-8. PubMed ID: 3708932
    [Abstract] [Full Text] [Related]

  • 29. Pathogenic factors in aminoglycoside-induced nephrotoxicity.
    Kacew S, Bergeron MG.
    Toxicol Lett; 1990 May; 51(3):241-59; discussion 237-9. PubMed ID: 2187280
    [Abstract] [Full Text] [Related]

  • 30. Comparative nephrotoxicity of four aminoglycosides: biochemical and ultrastructural modifications of lysosomes.
    Fillastre JP, Hemet J, Tulkens P, Morin JP, Viotte G, Olier B, Godin M.
    Adv Nephrol Necker Hosp; 1983 May; 12():253-75. PubMed ID: 6404138
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Experimental study on renal tolerability of aminoglycosides butirosin and bekanamycin (author's transl)].
    Beck H, Eikenberg P, Sack K.
    Arzneimittelforschung; 1980 May; 30(2):288-94. PubMed ID: 6155127
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Aminoglycoside nephrotoxicity. II. Transtubular transport and factors modifying aminoglycoside nephrotoxicity].
    Fabre J, de Sousa R.
    Nephrologie; 1980 May; 1(2):89-94. PubMed ID: 6170903
    [No Abstract] [Full Text] [Related]

  • 35. Comparative pathophysiology and histopathology of cyclosporine nephrotoxicity.
    Dieperink H, Starklint H, Kemp E, Leyssac PP.
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):785-91. PubMed ID: 3291315
    [No Abstract] [Full Text] [Related]

  • 36. Effect of aminoglycoside antibiotics on cellular functions of kidney epithelial cell line (LLC-PK1): a model system for aminoglycoside nephrotoxicity.
    Hori R, Yamamoto K, Saito H, Kohno M, Inui K.
    J Pharmacol Exp Ther; 1984 Sep; 230(3):724-8. PubMed ID: 6088764
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Drug-induced kidney disorders].
    Keusch G.
    Schweiz Med Wochenschr; 1982 Mar 13; 112(11):384-91. PubMed ID: 7071559
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.